Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GSK's Sandy Macrae On R&D For Emerging Markets: An Interview With PharmAsia News (Part 1 Of 2)

This article was originally published in The Pink Sheet Daily

Executive Summary

GSK's Senior VP Asia Pacific, Japan, and Emerging Markets R&D has been busy pitching the company's established presence in emerging markets to companies looking to expand beyond traditional markets, and even some that aren't.

You may also be interested in...

Amgen's Prolia Bags Favorable Draft Appraisal From UK Medicines Watchdog

NICE considers denosumab a cost-effective use of NHS resources for second-line osteoporosis use.

Red Hot Deal For Red Heart Pill - Dr. Reddy's In Talks With GSK For Combination Heart Drug

MUMBAI - India's Dr. Reddy's Laboratories and pharmaceutical major GlaxoSmithKline are in active discussions to partner on marketing a uniquely designed combination drug that can combat cardiovascular and cerebrovascular diseases and will be priced "very economically.

GSK Sees Emerging Market Opportunity In Thinking Locally, Developing Locally

SINGAPORE - GSK APJEM R&D is pretty hefty as far as acronyms go, but GlaxoSmithKline's Judith Hills wants to make sure observers do not over look the research and development title in the new GSK division





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts